Vaccine Effectiveness Against Influenza A, Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults With COVID-19, and Risk of New-Onset Long COVID Following Reinfection With SARS-CoV-2 | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

MicrobeTV

Vaccine Effectiveness Against Influenza A, Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults With COVID-19, and Risk of New-Onset Long COVID Following Reinfection With SARS-CoV-2

By MicrobeTV FEATURING Daniel Griffin, Vincent Racaniello

By MicrobeTV FEATURING Daniel Griffin, Vincent Racaniello

81 views

December 18, 2023

Comments 0

Login to view comments. Click here to Login